AI-generated analysis. Always verify with the original filing.
bioAffinity Technologies, Inc. filed an 8-K on 2026-03-13 disclosing results of operations under Item 2.02, with a press release attached as Exhibit 99.1. The filing includes financial statements and exhibits under Item 9.01.
Event Type
Disclosure
Mandatory
Variant
8-K
and in the press release attached as Exhibit 99.1 to this Current Report on Form 8-K shall not be incorporated by reference into any filing with the U.S. Securi
. Financial Statements and Exhibits. (d) Exhibits. The following exhibit is furnished with this Current Report on Form 8-K: Exhibit Description 99.1 Press Relea